Keros Therapeutics (KROS) Interest Coverage Ratio Growth (3y) (2022 - 2025)
Keros Therapeutics (KROS) Interest Coverage Ratio Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 40.09% |
| 10 | Keros Therapeutics | 383.75 Mn | 96.35 Mn | - | -26.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.13% |
| Sep 30, 2025 | -59.43% |
| Jun 30, 2025 | -93.94% |
| Mar 31, 2025 | 31.50% |
| Dec 31, 2024 | 77.09% |
| Sep 30, 2024 | -22.71% |
| Jun 30, 2024 | -62.25% |
| Mar 31, 2024 | -39.55% |
| Dec 31, 2023 | 10.86% |
| Sep 30, 2023 | -95.17% |
| Jun 30, 2023 | -72.06% |
| Mar 31, 2023 | -288.69% |
| Dec 31, 2022 | 87.03% |
| Sep 30, 2022 | 90.90% |
| Jun 30, 2022 | 90.86% |
| Mar 31, 2022 | 56.13% |